This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Juno Therapeutics Gmbh. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Neha Soni: Innovator in Immunotherapy
Introduction
Neha Soni is a prominent inventor based in Seattle, WA (US). She has made significant contributions to the field of immunotherapy, particularly in T cell modulation. Her innovative work has the potential to advance treatment options for various diseases.
Latest Patents
Neha Soni holds a patent for "Methods and combinations for treatment and T cell modulation." This patent relates to methods, compositions, and uses involving immunotherapies, such as adoptive cell therapy and T cell therapy. The disclosure includes immunomodulatory compounds, such as structural or functional analogs or derivatives of thalidomide and inhibitors of E3-ubiquitin ligase. The methods and compositions aim to enhance the activity, efficacy, persistence, expansion, and proliferation of T cells for adoptive cell therapy or endogenous T cells recruited by immunotherapeutic agents.
Career Highlights
Neha Soni is currently associated with Juno Therapeutics GmbH, where she continues to work on groundbreaking research in immunotherapy. Her expertise and innovative approach have positioned her as a key figure in the development of new therapeutic strategies.
Collaborations
Neha collaborates with notable professionals in her field, including Jens Hasskarl and Stanley R Frankel. These collaborations enhance the research and development of effective immunotherapeutic solutions.
Conclusion
Neha Soni's contributions to immunotherapy and T cell modulation exemplify her dedication to advancing medical science. Her innovative patent and ongoing work at Juno Therapeutics GmbH highlight her role as a leading inventor in the field.